All News #Library
Biotech
HingeBio Launches Phase 1 Trial of HB-2198 for Autoimmune Disease
14 Apr 2026 //
GLOBENEWSWIRE
Hinge Bio Gets FDA Nod For HB2198, In Lupus Therapy
13 Oct 2025 //
GLOBENEWSWIRE
Hinge Bio Collaborates With Kyorin Pharma On Hb2198
30 Sep 2025 //
GLOBENEWSWIRE
Hinge Bio Expands Leadership, Publishes GEM-DIMER Data
04 Sep 2025 //
GLOBENEWSWIRE
Hinge Bio Secures Major Funding For Advanced Therapy Platform
15 Jan 2025 //
GLOBENEWSWIRE
Hinge Bio Presents GEM-DIMER™ Data at ACR Convergence 2024
14 Nov 2024 //
GLOBENEWSWIRE
Hinge Bio CSO Daniel Capon To Present GEM-DIMER™ Tech At Oxford Conference
14 Aug 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support